Blog
- Lumisight (pegulicianine) Gains FDA Approval to Detect Residual Cancer
- Emerging drugs for the treatment of PNH
- FDA Approves First NASH Drug & Other Pipelines in Clinical Trials
- Top 10 Most Anticipated Drug Launches Of 2024
- siRNA Drugs: Challenges and Opportunities
- Top 10 Projected Best-Selling Drugs in 2024
- Oligonucleotide Drugs: Current Status and Challenges
- ADC in Combination with PD-1: Approvals and Clinical Trials
- FDA Approves Iptacopan for the Treatment of PNH
- Cyclic Peptides: Current Status & Future Prospects